title: Cardiovascular and Hematological Medicine in 2013  - Advances and Insights.
abstract: Welcome  to the first issue of Cardiovascular & Hematological Agents in  Medicinal Chemistry (CHAMC) for 2013. I hope everyone has had an  enjoyable holiday season and I want to wish everyone a wonderful New Year. As  you know, our journal (CHAMC) aims to cover the latest and outstanding  developments in medicinal chemistry, rational drug design for the discovery of  novel cardiovascular and hematological Agents and discusses such therapies in  clinical practice. Each issue contains a series of timely in-depth reviews,  original research articles and drug clinical trial studies written by leaders  in the field covering a range of current topics in cardiovascular and  hematological sciences. I feel that CHAMC is an essential journal for every  medicinal chemist, clinician and healthcare provider who wishes to be kept  informed and up-to-date with the latest and most important developments in  cardiovascular and hematological drug discovery and their clinical uses.    In  the coming issues of the journal, we will discuss several important topics  pertinent to chemists and clinicians in the cardiovascular and hematology  fields such as curcumin and resveratrol as alternative medicinal agents against  metabolic syndrome, interrelationship between chronic kidney disease and risk  of cardiovascular diseases and effects of direct renin inhibitor, aliskiren, on  arterial hypertension, chronic kidney disease and cardiovascular disease among  others. The journal also delves into hot topics such as genetic testing and  personalized medicine, use of literature-based discovery to identify novel  therapeutic approaches, pharmacologic mechanism and clinical relevance of P2Y12  inhibitors and intracoronary injection of glycoprotein IIb/IIIa, abciximab, as  adjuvant therapy in primary coronary intervention. Cardiovascular medicine and  hematology are both very dynamic fields with rapid advances and we will  continue to work to keep you up to date on new advances and therapies.  I  would also take this opportunity to invite our readers and experts to  contribute hot topics and general articles in their respective fields to our  journal. The journal is in its eleventh successful year  of publication, and is indexed by all major indexing media including Chemical  Abstracts, EMBASE/Excerpta Medica, Index Medicus/MEDLINE, BIOSIS Previews,  BIOSIS Reviews Reports and Meetings, Google, Google Scholar, Genamics  JournalSeek, MediaFinder®-Standard Periodical Directory and Scopus and remains  a valuable resource for chemists and clinicians.
authors.affiliation: Cardiovascular & Hematological Agents in Medicinal Chemistry. chamc@benthamscience.org.
authors.forename: Debabrata
authors.initials: D
authors.lastname: Mukherjee